Page 2 - Technology Venture Development News Today

Aurora, CO (PRWEB) October 14, 2021 -- Neurexis Therapeutics, Incorporated, announces it has been awarded a $496,145 grant from the National Institute of

VIC Technology Venture Development Announces New Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation Share Article Dr. Dennis Liotta and Dr. Paul Atkins “They are both innovative, life science veterans that have taken impactful technologies from the earliest stage to highly successful exits and we are fortunate to have them on our team.” said Calvin Goforth, Chief Executive Officer of VIC. FAYETTEVILLE, Ark. ...

Zebra Analytix Receives NIH Grant for Rapid Breath Detection of Hazardous Substance Exposure Share Article Enables screening of individuals working or living in close proximity to refineries, chemical plants, polluted cities and other environments. The funding from the National Institute of Environmental Health Sciences (NIEHS) corroborates the unmet need and significant opportunity in this space. FAYETTEVILLE, Ark. (PRWEB) March 1...

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19 Share Article VIC Foundry, in collaboration with Sandia National Laboratories, is developing a self-contained isothermal nucleic acid amplification test to address an unmet need for at-home testing of COVID-19 infection. VIC Foundry’s innovative designs for a low-cost at-home COVID-19 test Funding for the project is being provided by the National Institutes of Health (NIH) Rapid A...

Diabeloop SA. and SFC Fluidics Inc. announce development agreement for the United States Share Article SFC Fluidics Inc., developer of an Alternate Controller Enabled (ACE) insulin delivery pod and Diabeloop, pioneer in therapeutic artificial intelligence, are partnering to integrate the SFC ACE insulin pod into Diabeloop’s Automated Insulin Delivery solution. The agreement plans for a full US-adaptation of the system with a common mission - to bring the next generation of diabetes management...

CardioWise™ Receives US FDA 510(k) Clearance for Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ) Heart Function Analysis Software Share Article CardioWise, Inc., is pleased to announce Clearance of its 510(k) application by the US Food and Drug Administration (FDA) for its heart function analysis software, Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ). "CardioWise can now market the SQuEEZ analysis to provide give caregivers an easy-to-read, quantitative 4D color mode...